{"title":"Oscillatory fluid flow enhanced mineralization of human dental pulp cells.","authors":"Witsanu Yortchan, Sasima Puwanun","doi":"10.3389/fbioe.2025.1500730","DOIUrl":null,"url":null,"abstract":"<p><p>The purpose of this study is to evaluate the optimum frequency of oscillatory fluid flow (OFF) for increasing osteogenesis in human dental pulp cells (DPCs) in an incubating rocking shaker. DPCs from 3 donors were cultured in an osteogenic induction medium (OIM) and mechanical stimulation was applied using an incubating rocking shaker at frequencies of 0 (control), 10, 20, 30, and 40 round per minute (RPM) for 1 h/day, 5 days/week. Cell proliferation was measured using total protein quantification, and osteogenic activity was measured by alkaline phosphatase (ALP) activity, calcium deposition, and collagen production on days 7, 14, and 21 of culture. Results of DPCs morphology in the 30 RPM group were more clustered and formed interconnections between cells. Results of DPC proliferation and collagen production showed no significant differences between the experiment groups. The ALP activity on day 7 and 14, and calcium deposition on day 21 of the 30 RPM group were significantly higher than the control groups. Thus 30 RPM is likely an effective frequency for increasing calcium deposition. This study uses strategies in Tissue Engineering followed the research topic about an application of human cells to stimulate oral and maxillofacial hard tissue regeneration. In the future, the mineralization of DPCs could be enhanced by using an incubating rocking shaker at 30 RPM in the lab to create a cell sheet. The mineralized cell sheet could then be implanted into the patient for bone repair of orofacial defects.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1500730"},"PeriodicalIF":4.3000,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11774892/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1500730","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The purpose of this study is to evaluate the optimum frequency of oscillatory fluid flow (OFF) for increasing osteogenesis in human dental pulp cells (DPCs) in an incubating rocking shaker. DPCs from 3 donors were cultured in an osteogenic induction medium (OIM) and mechanical stimulation was applied using an incubating rocking shaker at frequencies of 0 (control), 10, 20, 30, and 40 round per minute (RPM) for 1 h/day, 5 days/week. Cell proliferation was measured using total protein quantification, and osteogenic activity was measured by alkaline phosphatase (ALP) activity, calcium deposition, and collagen production on days 7, 14, and 21 of culture. Results of DPCs morphology in the 30 RPM group were more clustered and formed interconnections between cells. Results of DPC proliferation and collagen production showed no significant differences between the experiment groups. The ALP activity on day 7 and 14, and calcium deposition on day 21 of the 30 RPM group were significantly higher than the control groups. Thus 30 RPM is likely an effective frequency for increasing calcium deposition. This study uses strategies in Tissue Engineering followed the research topic about an application of human cells to stimulate oral and maxillofacial hard tissue regeneration. In the future, the mineralization of DPCs could be enhanced by using an incubating rocking shaker at 30 RPM in the lab to create a cell sheet. The mineralized cell sheet could then be implanted into the patient for bone repair of orofacial defects.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.